News
-
-
-
PRESS RELEASE
APONTIS PHARMA AG appoints CFO Thomas Zimmermann to the Management Board with a view to the strategic development of the Company
APONTIS PHARMA AG appoints CFO Thomas Zimmermann to the Management Board to enhance strategic development, internationalization, and ESG strategy. CFO brings strong financial expertise -
-
-
PRESS RELEASE
Original-Research: APONTIS PHARMA AG (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research initiates coverage on APONTIS PHARMA AG with a Buy rating and EUR 17.00 price target. Apontis focuses on cardiovascular and respiratory drugs in Germany, led by CEO Wohlschlegel to drive efficiency and growth -
-
-
PRESS RELEASE
EV Nickel Provides Update on 2024 Exploration Plan - Initiates Diamond Drill Program on High Grade Target
EV Nickel Inc. (TSX-V:EVNI) provides update on 2024 Exploration Plan, diamond drilling on Langmuir #2 high priority nickel target. Expanding activities on CarLang resource, drilling high-grade targets, advancing clean metal bioleaching program -